Growing an antimicrobial stewardship program: A case study at Boston Medical Center

In a recent post to the reSOURCEs section of its public website, HealthTrust focused in on Boston Medical Center’s pharmacy-based antimicrobial stewardship team.

Advertisement

The roll out of the program began in 2004, according to the post, with one of it’s first initiatives being to revise the antibiotic restriction policy.

Since then, the team has created 17 specific clinical pathways for conditions such as

– Skin/Soft tissue infections
– Urinary Tract Infections
– Acute Bacterial Meningitis
– Pelvic Inflammatory Disease.

All of these pathways are available to BMC staff on the Internet and the hospital’s EHR.

With guidelines, pathways and policies set, what is next for the team?

Patient-level recommendations and employing a prospective audit and feedback method.

Chief Pharmacy Officer at BMC, David Twitchell, noted on the program’s future.

“At first, the antimicrobial stewardship program was largely retrospective, big-picture review of past usage and misadventures, trying to education people to do better in the future…Today, we’re targeting areas of misuse, and reports issued each morning enable Dana and Kelly to immediately intervene.”

Dana Whitney and Kelly Wright are on the program’s core team.

To read more about BMC and its program, click here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.